Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
- PMID: 27905921
- PMCID: PMC5134107
- DOI: 10.1186/s12936-016-1624-8
Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?
Abstract
Background: Levels of both angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) correlate with malaria disease severity and are proposed as biomarkers and possible therapeutic targets. To establish their role in malaria, a systematic review was performed of the literature on Ang-1 and Ang-2 with regard to their potential as biomarkers in malaria and discuss their possible place in adjuvant treatment regimens.
Methods: Ten electronic databases were systematically searched to identify studies investigating Ang-1 and Ang-2 in human and murine malaria in both clinical and experimental settings. Information about the predictive value of Ang-1 and Ang-2 for disease severity and their regulatory changes in interventional studies were extracted.
Results: Some 579 studies were screened; 26 were included for analysis. In all five studies that determined Ang-1 levels and in all 11 studies that determined Ang-2 in different disease severity states in falciparum malaria, a decline in Ang-1 and an increase of Ang-2 levels was associated with increasing disease severity. All nine studies that determined angiopoietin levels in Plasmodium falciparum patients to study their ability as biomarkers could distinguish between multiple disease severity states; the more the disease severity states differed, the better they could be distinguished. Five studies differentiating malaria survivors from non-survivors with Ang-2 as marker found an AUROC in a range of 0.71-0.83, which performed as well or better than lactate. Prophylactic administration of FTY720, rosiglitazone or inhalation of nitric oxide (NO) during malaria disease in mice resulted in an increase in Ang-1, a decrease in Ang-2 and an increased survival. For rosiglitazone, a decrease in Ang-2/Ang-1 ratio was observed after post-infection treatment in mice and humans with malaria, but for inhalation of NO, an effect on Ang-1 and survival was only observed in mice.
Conclusion: Both Ang-1 and Ang-2 levels correlate with and can distinguish between malaria disease severity states within the group of malaria-infected patients. However, distinct comparisons of disease severity states were made in distinct studies and not all distinctions made had clinical relevance. Changes in levels of Ang-1 and Ang-2 might also reflect treatment effectiveness and are promising therapeutic targets as part of multi-targeted therapy.
Keywords: Angiopoietin-1; Angiopoietin-2; Biomarker; Endothelial cell activation; Malaria; Therapeutic target.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5134107/bin/12936_2016_1624_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/5134107/bin/12936_2016_1624_Fig2_HTML.gif)
Similar articles
-
Angiopoietin as a Novel Prognostic Marker in Kidney Disease.Blood Purif. 2024;53(6):425-435. doi: 10.1159/000536439. Epub 2024 Jan 23. Blood Purif. 2024. PMID: 38262381 Review.
-
Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia.PLoS One. 2014 Oct 2;9(10):e109246. doi: 10.1371/journal.pone.0109246. eCollection 2014. PLoS One. 2014. PMID: 25275496 Free PMC article.
-
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.Malar J. 2011 Dec 23;10:383. doi: 10.1186/1475-2875-10-383. Malar J. 2011. PMID: 22192385 Free PMC article.
-
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria.Malar J. 2009 Dec 15;8:295. doi: 10.1186/1475-2875-8-295. Malar J. 2009. PMID: 20003529 Free PMC article.
-
Serum angiopoietin-1 and -2 levels discriminate cerebral malaria from uncomplicated malaria and predict clinical outcome in African children.PLoS One. 2009;4(3):e4912. doi: 10.1371/journal.pone.0004912. Epub 2009 Mar 20. PLoS One. 2009. PMID: 19300530 Free PMC article.
Cited by
-
Unravelling mysteries at the perivascular space: a new rationale for cerebral malaria pathogenesis.Trends Parasitol. 2024 Jan;40(1):28-44. doi: 10.1016/j.pt.2023.11.005. Epub 2023 Dec 8. Trends Parasitol. 2024. PMID: 38065791 Free PMC article. Review.
-
Histomorphometric features of placentae from women having malaria and HIV coinfection with preterm births.medRxiv [Preprint]. 2023 Oct 31:2023.10.30.23297751. doi: 10.1101/2023.10.30.23297751. medRxiv. 2023. PMID: 37961170 Free PMC article. Preprint.
-
Endothelial transcriptomic analysis identifies biomarkers of severe and cerebral malaria.JCI Insight. 2023 Nov 22;8(22):e172845. doi: 10.1172/jci.insight.172845. JCI Insight. 2023. PMID: 37788095 Free PMC article.
-
Elevated brain derived neurotrophic factor in plasma and interleukin-6 levels in cerebrospinal fluid in meningitis compared to cerebral malaria.J Neurol Sci. 2023 Jul 15;450:120663. doi: 10.1016/j.jns.2023.120663. Epub 2023 May 2. J Neurol Sci. 2023. PMID: 37182424
-
Diagnosis of cerebral malaria: Tools to reduce Plasmodium falciparum associated mortality.Front Cell Infect Microbiol. 2023 Feb 9;13:1090013. doi: 10.3389/fcimb.2023.1090013. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36844403 Free PMC article. Review.
References
-
- WHO. World malaria report. Geneva: World Health Organization; 2015.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous